跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAN-204
首页
药物
CAN-204
CAN-204
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Genes associated to sucrose content
US 7732664 B2
申请人: UNIV SAO PAULO
优先权: 2007
US
5 件公开
OLIGONUCLEOTIDE FOR MIR-204, AND COMPOSITION FOR ALLEVIATING, PREVENTING OR TREATING OSTEOARTHRITIS, COMPRISING SAME
WO 2026142081 A1
申请人: LIFLEX SCIENCE INC
优先权: 2024
CN
WO
2 件公开
Colostral fractionation process
US 7547770 B2
申请人: ADVANCED PROTEIN SYSTEMS
优先权: 2004
US
2 件公开
Artificial Immunoglobulin Fragment Composition
US 2015166645 A1
申请人: UNIV CHIBA NAT UNIV CORP
优先权: 2015
US
2 件公开
Traditional Chinese medicine physiotherapy sickbed and using method thereof
CN 111568667 A
申请人: BEIJING LUOBIDA TECH CO LTD
优先权: 2018
CN
2 件公开
METHOD AND CYCLER FOR PERITONEAL DIALYSIS
WO 0119430 A1
申请人: GAMBRO LUNDIA AB
优先权: 1999
WO
SiRNA for restraining melanin, preparation method and application
CN 1600858 A
申请人: XINYANG BIOTECH CO LTD FUDAN S
优先权: 2004
CN
3,6-dichloro-9-(2-(4-methylpiperazine-1-yl)ethyl)-9H-carbazole and preparation method thereof
CN 101456839 A
申请人: UNIV NORTH CHINA
优先权: 2008
CN
miRNA and application of miRNA in preparation of product for diagnosing and treating posterior capsule opacification
CN 103773764 A
申请人: SHANDONG EYE INST
优先权: 2012
CN
Novel crystal form of ibrutinib and preparation method thereof
CN 105085529 A
申请人: GUANGDONG HEC PHARMACEUTICAL
优先权: 2014
CN
第 1 / 4 页
上一页
下一页
药物
反馈